Embryonic Stem Cells Survive Freezing

Even after 18 years of frozen storage, human embryos can still produce viable stem cells for drug screening and biomedical research.

Written byHayley Dunning
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Cryopreservation of embryos in fertility centers is common, and concerns over damage to the embryo during thawing were largely allayed by the birth of a healthy boy in 2010 from 20-year old cryopreserved embryo. Last week (August 10), researchers in Thailand reported in BioResearch Open Access that they successfully induced the growth of stem cells from a set of 17- and 18-year-old frozen embryos.

The embryos were thawed, then cultured to the blastocyst stage and co-cultured with human foreskin fibroblasts which acted as feeder cells to maintain the growth of embryonic stem cells. The team used the same method to induce stem cells to grow from fresh embryos for comparison, and in cells from both sources they found similar levels of pluripotency.

“The importance of this study is that it identifies an alternative source for generating new embryonic stem lines, using embryos that have been in long-term storage,” BioResearch Open ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies